Zoetis Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares fell 1.54% to $74.19 on Wednesday, underperforming competitors like Merck & Co. and IDEXX Laboratories during a broader market decline. This marks the fourth consecutive day of losses for Zoetis, with the stock trading significantly below its 52-week high. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) slipped 1.54% to $74.19 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58.
This was the stock's fourth consecutive day of losses.
Zoetis Inc. closed 53.77% short of its 52-week high of $160.48, which the company reached on August 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Merck & Co. Inc. (MRK) rose 0.96% to $127.47 and IDEXX Laboratories Inc. (IDXX) fell 1.35% to $545.00.
Trading volume (4.7 M) remained 3.1 million below its 50-day average volume of 7.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-22-26 1656ET